Courts blocked Apple from enabling blood oxygen sensors in the Apple Watch due to patent infringement on medical device company Masimo, which holds over 1,500 medical technology patents.

Kiani has been in it since starting Masimo in 1989. Along with being chairman and CEO, he holds more than 500 patents or patent applications related to advanced signal processing, optical sensors ...

Masimo Corporation (NASDAQ:MASI) disclosed Friday that it received unsolicited offers from potential acquirers for its ...

Masimo has announced collaborations with Google and Qualcomm to build a Wear OS reference platform. This reference platform will feature the Snapdragon W5 Plus Gen 1 processor and Masimo’s ...

This includes both underlying hardware (health sensors) and a smartphone app. Manufacturers will also have access to Masimo’s advanced health monitoring technologies. Interested manufacturers ...

Masimo (NASDAQ:MASI) partners with Google (GOOG) to develop a new reference platform for original equipment manufacturers ((OEMs)) building Wear OS by Google smartwatches. OEMs who adopt the new ...

With decades of expertise, Masimo is now able to make SET ® available not only for traditional hospital bedside monitoring, but in tetherless sensors that promote freedom of movement, in wearable ...

IRVINE, Calif., September 16, 2024--(BUSINESS WIRE)--Masimo Corporation ("Masimo" or the "Company") (NASDAQ: MASI), a global leader in noninvasive monitoring ...

Masimo Corp.’s annual shareholder meeting, scheduled for Sept. 19, will determine whether Joe Kiani will remain as chairman of the company he co-founded in 1989. The Irvine maker of non-invasive ...

Masimo Corporation MASI, on Friday, announced a partnership with Google. The tie-up aims to develop a new reference platform for original equipment manufacturers (OEMs) building Wear OS by Google ...